Constraint 鬱 as a Window on Approaches to Emotion-Related Disorders in East Asian Medicine by Scheid, V. & Scheid, V.
1 23
Culture, Medicine, and Psychiatry







Cult Med Psychiatry (2013) 37:2-7
DOI 10.1007/s11013-012-9300-0
Constraint 鬱 as a Window on Approaches




Your article is published under the Creative
Commons Attribution license which allows
users to read, copy, distribute and make
derivative works, as long as the author of
the original work is cited. You may self-
archive this article on your own website, an
institutional repository or funder’s repository
and make it publicly available immediately.
INTRODUCTION
Constraint 鬱 as a Window on Approaches
to Emotion-Related Disorders in East Asian Medicine
Volker Scheid
Published online: 20 December 2012
© The Author(s) 2012. This article is published with open access at Springerlink.com
According to widely publicized WHO data “depression” is an epidemic that by 2020
is set to become the second most important cause of disease throughout the world
(World Health Organization 2012). Yet, what the WHO identifies as an emerging
pandemic requiring a coordinated global response, more critical voices see as the
unreflective application of problematic disease labels that fail to understand and
therefore help real patient needs (Summerfield 2006). These critics hold that the
classification systems that define psychiatric disorders—the InternationalClassiﬁcation
of Diseases (ICD) and the Diagnostic and Statistical Manual of Mental Disorders
(DSM)—are based on self-descriptions of mental states elicited from patients living in
advanced capitalist societies and draw on historically specific definitions of disease,
evidence, and facts. In that sense, they constitute “western cultural documents par
excellence” (Summerfield 2008). Far from objectively assessing mental health they
seek to shape specificwaysof citizenship andofbeing a person that, rather conveniently,
match the western neoliberal economic order. Displacingmodes of dealing withmental
health issues that emphasize interpersonal relationships or social and economic causes,
depression thus becomes just one more condition that reflects and sustains globally
dominant networks of consumption and control in the twenty first century.
Globalization, however, works in many different directions at the same time. Thus,
even asDSM and ICD arewesternizing the understanding and treatmentmental health
issues around theworld, health care in theWest itself is slipping away from the control
of biomedicine and is now, de facto plural. Mirroring the increasing importance of
Asian economies on the global stage East Asian medicines are amongst the most
influential of the many so-called complementary and alternative medicines (CAM)
that now compete with biomedicine in the global health care market. Tracing their
origins back hundreds or even thousands of years, none of these medicines knew of
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“depression” in the manner constituted by ICD or DSM before the final decades of the
twentieth century. And yet, the physicians that practice these healing arts around the
world today offer solutions for depressive disorders based on what they claim to be
thousands of years of clinical experience (Yuan 2009).
How East Asian medicine doctors have adapted their traditions to the treatment
of this very modern disease and what questions this raises for humanities scholars,
clinicians, patients, and regulators are the stories that the four articles collected in
this issue take up. But before we begin, we must clear the decks for readers who are
not familiar with “traditional medicine” in East Asia and for those who are more
accustomed to view them through a contemporary lens.
First, we note that thinking of East Asian medicines as distinct “national”
medical traditions is a relatively recent phenomenon and one that is intimately
related to the emergence of the nation state. We argue, instead, that the medical
practices of East Asia constitute a unified field, albeit a unity that is loose like the
“family resemblance” of Wittengenstein’s language games rather than that of a
closed system. Such family resemblance is founded in a shared debt to early
Chinese medical texts and maintained by an ongoing exchange of knowledge and
technology across the region. In relation to the topic at hand, we clearly see this
family resemblance in the fact that despite the many explicit and implicit
differences of traditional medical practices in China, Japan, and Korea today, they
all approach depression by way of the same concept, that of constraint 鬱 (Chin.
yù; Jap. utsu; Kor. ul).
Second, we reject the notion of “traditional” medicine in the sense that it is
conventionally employed: that is, as a set of medical practices so integrally linked to
its origins that, unlike modern science or biomedicine, it is incapable of profound
change. What our papers show, instead, are fundamental transformations in
knowledge structures and clinical practice in how East Asian medicines deal with
emotion-related disorders through a shared focus on constraint. Some of these
transformations occur gradually over centuries while others transpire in decades or
less. Some of these changes result from the encounter with modern biomedicine but
most took place long before that time. Hence, unlike the impact-response model that
guides so much modernization theory, where a passive East is spurred to change
only through the climatic encounter with a dynamic West, we do not find these more
recent transformations to be determinative. Instead, we hold that the key to
understanding how physicians today are responding to the clinical problem of
depression can only be located in the broader trajectories of East Asian medicine.
We emphasize the word “trajectories” because we find multiple developmental
trends that shape the history of medicine across the region.
Scheid, in the first paper in this collection, traces the slow process by which the
concept of constraint in late imperial China gradually became associated with
emotion-related disorders, with liver system pathologies and, at least in the eyes of
some physicians, with a very narrow range of specific treatment regimes. This
implied a profound re-interpretation of earlier ideas contained in the foundational
texts of East Asian medicines that associated constraint specifically with externally
contracted pathogens and with the Lungs. Furthermore, these transformations were
enacted primarily in southeast China among an elite stratum of physicians and their
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patients, reflecting locally specific gender identities and notions of constitution, as
well as an ambivalence to the role of emotions in human life. These ideas and
practices thus do not in any meaningful way represent “China” as either a political,
cultural, or historical entity. Yet, their cultural dominance ensured that they became
the foundations on which physicians in contemporary China constructed “traditional
Chinese medicine” (TCM).
Having moved to Japan between the twelfth and sixteenth centuries, notions of
constraint came to dominate medical thinking there, too, though in ways that were at
once similar and radically different from the sources they had initially borrowed.
Daidoji, in the second paper of this issue, examines multiple strands of these
transformations between the seventeenth and twentieth centuries. She convincingly
demonstrates that even as contemporary practices share a certain family
resemblance with premodern ones, or those in Edo Japan with those in Ming
dynasty China, they are not in any narrow sense transforming out of each other.
Rather, she uncovers a distinctive change in Kampo practice during the late
nineteenth century, whereas earlier transformations emerge as highly contextual
synthesis, driven by the idiosyncratic thought styles of individual physicians and the
vagaries of Japanese translations of Chinese terms as much as the specific socio-
cultural contexts in which such production occurred.
An important characteristic of this context was the increasing turn towards
empirical observation as the foundation of medical practice among leading
physicians in Edo Japan. This empiricist turn later inspired physicians in Republican
China faced with the increasing visibility of medical practices imported from the
West. As Karchmer shows in his essay, modernizing Republican era physicians used
this “interruption” as an opportunity to move their tradition towards a path that was
at one and the same time rooted in western anatomy and the most ancient medical
texts from which physicians had significantly departed long since. In doing so, they
connected the nerves and ideas about nervous weakness (or neurasthenia), then just
as a much a global epidemic as depression is today, to Chinese medical conceptions
of the liver and liver disease. Along the way, they conveniently ignored the debt
they owed to the post-Song physicians they so despised, who had moved the liver to
the forefront of medical thinking in all cases of emotion-related disorders. Likewise,
while Chinese medicine physicians in contemporary China have largely abandoned
Republican era attempts to create convergences between the Chinese and western
medical bodies in favor of delineating clear differences between their respective
medical systems, modern interpretations of emotion-related disorders and constraint
as predominantly a liver system disorder are a direct continuation of Republican era
practices.
In the final essay of this issue, Soyoung Suh examines Korean responses to an
emotion-related disorder endemic to contemporary Korea, that of fire illness or
hwa-byung 火病. Also known as ui-hw-byung 鬱火病, which can be translated as
“constraint [leading] to fire illness”, the term is redolent of post-Song interpretations
of constraint that viewed fire (i.e., heat symptoms) as one of the most common
developments of constraint disorders. Yet, the prevalence of the disease in Korea is
rooted not in medical transmission but in contemporary popular culture to which
both biomedically trained psychiatrists and practitioners of Korean medicine were
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forced to find new answers. Such attempts invariably raised questions about what
was specifically Korean about this disorder and how it related to both biomedical
disease categories such as depression and anxiety and to traditional disease concepts
of emotional disorders imported from China. Suh argues that ultimately such efforts
must be seen attempts to define ones identity in a context where the desire for
autonomy is enacted in (neo)colonial discursive formations that are both present and
absent to the actors Suh observes.
What emerges from the four essays then is not a single internally consistent
history whereby indigenous notions of constraint come to be connected to the
biomedical disease category of depression. Rather, physicians in China, Japan, and
Korea assemble valid responses—valid because peers, patients, researchers, and
regulators take them seriously—to newly emergent medical problems through
highly contextual processes of synthesis. Yet, we would argue that a thick
description of these processes that uncovers all of the various threads that contribute
to these assemblages, is only possible through the kind of trans-local longue durée
approach we have taken here. By trans-local, we mean that all of the practices and
transformations we have described here invariably relate themselves to somewhere
and something else: to a shared archive of medical texts; to lineages of transmission
and scholarship; to established formulas or treatment strategies; to medicinals
imported from different places and diagnostic technologies developed at different
times. These elements themselves are equally fluid in their composition and forever
travel between sites of articulation with scant respect for boundaries, territorial or
otherwise. By emphasizing the concept of longue durée we acknowledge that what
unites all of these transformations is their relation to the concept of constraint and
therefore, at an even deeper level, to that of qi.
Read together our essays thus insert themselves into a number of different
debates. At the most basic level, they sketch the history of constraint in East Asian
medicine from a transnational perspective. They reveal that history to proceed along
a number of different trajectories all of which point back to a common origin: the
appropriation of Han dynasty concepts of constraint by a small group of physicians
in post-Song China from where they dispersed, via various routes, across all of East
Asia. These notions were successfully articulated and re-articulated into diverse
local contexts of practice but only some of these currents carried all the way into the
present to successfully articulate constraint with depression. Of these, TCM’s
linkage of depression with the concept of liver qi constraint has been by far the most
successful synthesis. Indeed, as described by Scheid and Karchmer, it is this linkage
that establishes contemporary TCM as the only truly global alternative to
psychiatry-based interventions in the treatment of depression. Other contemporary
syntheses have, so far, remained local or regional, though this may well change in
the future. Supported by the Korean state, Korean physicians are currently engaged
in strenuous attempts to globalize their medicine, too. If successful, this would set
up a situation in which two articulations that connect constraint to depression but
utilize entirely different treatment approaches would compete with each other as
well as with psychiatric treatments. Even more interesting, some of the treatment
strategies that endure in Korea and Japan to this date belong to currents that have
virtually disappeared in China itself.
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Such histories are not merely of intellectual interest but have important practical
implications. If the universalizing efforts of Chinese and Korean traditional
medicines are clearly tied to nationalist agendas, global users of these medicines are
motivated by different goals. Sooner or later—and the collection of these essays is
already a part of this process—competing histories and legitimizing strategies must
come into conflict with each other. For even as TCM promotes itself as an
alternative to biomedical psychiatry, the endurance of pre-TCM currents of practice
in contemporary Korea challenges TCM’s claims to represent Chinese medicine
tout court. This, in turn, will draw renewed attention to the many different currents
of practice that persist within the Chinese, Korean, and Japanese medical traditions.
Not only patients but also clinicians and researchers interested in East Asian
medicines will thus have to ask entirely new set of questions: not merely whether or
not something works and how one might go about evaluating it, but which of several
alternatives one should focus one’s evaluations on. As our stories show, the mere
endurance into the present of a given formula, treatment approach or medical
current has many different reasons of which clinical effectiveness is but one among
others.
On a second level, our essays can also be read as a contribution to our
understanding of the much analyzed process of globalization. As noted above, in the
domain of cross-cultural psychiatry this is most commonly explored by examining
how one specific ethnomedicine, biomedical psychiatry, succeeds in establishing a
universally accepted normative discourse, as well as charting accommodation/
resistance to that discourse. Attempts to assimilate indigenous disease categories
relating to constraint (such a yu in China or hwa-byung in Korea) to ICD and DSM
standards certainly fit into these established narratives. Yet, this narrative is
challenged by the de facto globalization of TCM constraint, which circumvented
establishment networks even as it used them to its own advantage. After all, the
more patients are labeled as suffering from depression by psychiatrists, the larger
the pool of potential patients looking towards TCM for alternative treatment.
Moreover, the regional flow of ideas and practices relating to the notion of
constraint within East Asia, beginning centuries before the encounter of local
medical traditions with the West challenges the idea that current processes of
globalization are categorically different to what went on before. Instead, by
highlighting the enduring importance of regional flows to the constitution of East
Asian medicines the modern opposition between the local and the global is
interrupted. This creates space for escaping from the narratives of accommodation/
resistance that define the response/impact model of modernization and for focusing,
instead, on the necessary trans-local nature of the emergent syntheses that construct
the practices we describe.
Such a refocusing will necessitate of historians and anthropologists to recalibrate
their attention to mapping, analyzing, and comparing what allows some trajectories
to extend across time and space, while others lead into cul-de-sacs. One factor,
certainly, that allowed the TCM concept of liver qi constraint to travel around the
world so quickly was its ability to translate a wide range of emotion-related
disorders into a single disease category without thereby disconnecting it from the
wider discourse of qi that defines East Asian medicines. This is fundamentally
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different from the work of biomedically oriented researchers in Korea and Hong
Kong, whose attempts to insert notions of constraint into the field of psychiatry
forced them to surrender such attachments, effectively disconnecting them from
East Asian medical practice.
This, then, is the final point we wish to make. Dealing with a range of problems
embodied in what is, after all, the same biological body, psychiatrists and East Asian
medicine physicians arrive at essentially similar solutions: pharmacotherapy and
talking-therapies. Where they differ is in the mobilization of fundamentally different
conceptions of the body/person that constitute their medicines trans-locally. In East
Asian medicine, as long as illness is grasped via the concept of constraint, such
grasping involves an acknowledgement of the reality of qi flow and transformation;
and because qi flow transcends the divisions that psychiatrists make between
emotions, the mind, and the body their different trajectories can touch without
threatening each other’s integrity. They can only converge, however, by one
dominating the other, or by creating something entirely new. As the histories collected
here demonstrate, such disappearance is the invariable price of any process of
synthesis and emergence.
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